Premature decline in serum insulin-like growth factor-1 in diabetic patients (type 2) and its correlation with the development of diabetic microvascular complications

Serum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma

Serum insulin like growth factor-I indiabetic patients with macrovascular complications

The relation between plasma concentration of osteopontin, matrix metalloprotinase-2 and severity of diabetes mellitus

Estimation of TGF beta-1 as a marker of renal injury in type II diabetes

The possible role of matrix metalloproteinase-2 as a marker of micoangiopathy in type 1 diabetes mellitus, relation to ACE-I

Laminin and chromogranin a levels in patients with liver cirrhosis

High sensitivity c-reactiveprotein in type 2 diabetesmellitus with vascularcomplications

Laminin and syndecan-1 levels as biomarkers in patients with hepatitis C

Serum levels of fibroblast growth factor-21 (FGF 21) in coronary heart disease